# Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andreas Wollenberg,Andrew Blauvelt,Emma Guttman‐Yassky,Margitta Worm,Charles Lynde,J.‐P. Lacour,Lynda Spelman,Norito Katoh,Hidehisa Saeki,Yves Poulin,Aleksandra Lesiak,Leon Kircik,S.H. Cho,Pedro Herranz,Michael J. Cork,Ketty Peris,Louise Abildgaard Steffensen,B K Bang,Alexandra Kuznetsova,T.N. Jensen,Marie Louise Østerdal,Eric L. Simpson,the ECZTRA 1 and ECZTRA 2 study investigators |
| Citations | 612 |
| DOI | 10.1111/bjd.19574 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19574 |
| OpenAlex ID | https://openalex.org/W3091046625 |
| PMID | 33000465 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Andreas Wollenberg](https://scholariq.org/researchers/andreas-wollenberg/)
- [Margitta Worm](https://scholariq.org/researchers/margitta-worm/)
- [Pedro Herranz](https://scholariq.org/researchers/pedro-herranz/)
- [Hidehisa Saeki](https://scholariq.org/researchers/hidehisa-saeki/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.